Literature DB >> 4321477

ynergy of ethanol and a natural soporific--gamma hydroxybutyrate.

E R McCabe, E C Layne, D F Sayler, N Slusher, S P Bessman.   

Abstract

gamma-Hydroxybutyrate and ethanol, as well as gamma-butyrolactone and ethanol are potentiative with respect to duration of loss of the righting reflex (sleep time). The concentration of ethanol in the liver decreases from 30 to 90 minutes after rats are injected with ethanol, but there is no change when ethanol is injected with gamma-butyrolactone. In view of the fact that gamma-hydroxybutyrate is a natural intermediate in brain, the effects of ethanol on the central nervous system may be mediated through its interaction with gamma-butyrolactone.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4321477     DOI: 10.1126/science.171.3969.404

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Acute poisoning from gamma-hydroxybutyrate in California.

Authors:  M Y Chin; R A Kreutzer; J E Dyer
Journal:  West J Med       Date:  1992-04

2.  Impact of strain, sex, and estrous cycle on gamma butyrolactone-evoked absence seizures in rats.

Authors:  Victor R Santos; Ihori Kobayashi; Robert Hammack; Gregory Danko; Patrick A Forcelli
Journal:  Epilepsy Res       Date:  2018-09-18       Impact factor: 3.045

3.  Hypnogenic properties of succinic semialdehyde and its fatty acid derivatives.

Authors:  G A Kerkut; P V Taberner
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

4.  Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice.

Authors:  Charles D Cook; Laura Biddlestone; Andrew Coop; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2006-02-02       Impact factor: 4.530

5.  Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies.

Authors:  Bridget L Morse; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2013-06-28       Impact factor: 4.030

Review 6.  The Xyrem risk management program.

Authors:  David E Fuller; Carl S Hornfeldt; Judy S Kelloway; Pamela J Stahl; Todd F Anderson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.